Optimizing management of stable angina: a patient-centered approach integrating revascularization, medical therapy, and lifestyle interventions

RA Montone, R Rinaldi, G Niccoli, G Andò… - Journal of the American …, 2024 - jacc.org
Angina pectoris may arise from obstructive coronary artery disease (CAD) or in the absence
of significant CAD (ischemia with nonobstructed coronary arteries [INOCA]). Therapeutic …

Percutaneous revascularization for ischemic left ventricular dysfunction: cost-effectiveness analysis of the REVIVED-BCIS2 trial

C Chivardi, H Morgan, MJ Sculpher… - … Quality and Outcomes, 2024 - Am Heart Assoc
BACKGROUND: Percutaneous coronary intervention (PCI) is frequently undertaken in
patients with ischemic left ventricular systolic dysfunction. The REVIVED (Revascularization …

International Systematic Review of Utility Values Associated with Cardiovascular Disease and Reflections on Selecting Evidence for a UK Decision-Analytic Model

R Hainsworth, AJ Thompson, B Guthrie… - Medical Decision …, 2024 - journals.sagepub.com
Purpose Evaluating interventions for cardiovascular disease (CVD) requires estimates of its
effect on utility. We aimed to 1) systematically review utility estimates for CVDs published …

A Cost-Consequence Analysis Comparing Balloon-Expandable Covered Stents for the Management of Aortoiliac Occlusive Disease

TM Warburton, SD Thomas, A Holden… - Journal of …, 2024 - journals.sagepub.com
Purpose: To compare procedural and long-term costs associated with the use of Balloon-
Expandable Covered Stents (BECS) in the management of Aortoiliac Occlusive Disease …

Cost effectiveness analysis of drug coated balloon only angioplasty for de novo coronary artery disease

I Merinopoulos, T Gunawardena… - Catheterization and …, 2023 - Wiley Online Library
Aims We aimed to perform a cost analysis of drug coated balloon (DCB)‐only angioplasty
versus drug eluting stent (DES), for de novo disease of all vessel sizes and all clinical …

Trends in the cost-effectiveness level of percutaneous coronary intervention: Macro socioeconomic analysis and health technology assessment

T Takura, I Komuro, M Ono - Journal of Cardiology, 2023 - Elsevier
Percutaneous coronary intervention (PCI), one of the most prevalent techniques of
revascularization, is a procedure that remarkably improves treatment outcomes. However, it …

The clinical value and cost-effectiveness of treatments for patients with coronary artery disease

H Weiting, AZ Yaoxian, YK Keong, SW Lam… - Health Economics …, 2022 - Springer
Background The clinical value and cost-effectiveness of invasive treatments for patients with
coronary artery disease is unclear. Invasive treatments such as coronary artery bypass …

Do coronary stent policies affect the cost-effectiveness of percutaneous coronary intervention among patients with acute coronary syndrome in Shanghai? A …

D Lu, Z Shao, Y Wang, D Xue - BMJ open, 2024 - bmjopen.bmj.com
Objectives This study aimed to assess whether the national centralised volume-based
procurement policy and the Shanghai government's supportive measures (coronary stent …

Cost-Effectiveness in Patients Undergoing Revascularization of Chronic Total Occluded Coronary Arteries—A Cohort Study

EN Holck, NS Winther, LJH Mogensen… - Frontiers in …, 2022 - frontiersin.org
Background Revascularization of patients with chronic total occluded coronary arteries
(CTO) is recommended if they have symptoms despite medical treatment. The cost …

[HTML][HTML] A debate.«Orbitando» en torno al abordaje de la angina estable. Perspectiva del clínico

D Vivas - REC: Interventional Cardiology, 2024 - SciELO Espana
vol. 6 número3 A debate.«Orbitando» en torno al abordaje de la angina estable.
Perspectiva del intervencionista Proyecciones angiográficas basadas en TC para planificar …